GlassScriptPhysician profile
Curtis Mack Healey
NPI 1922021427
$14,968.89
in general payments reported to CMS, 2019-2025
62 companies · $2,314 in 2025
The $2,314 reported for 2025 was more than what 97% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,593 · 2020: $1,592 · 2021: $2,222 · 2022: $2,194 · 2023: $2,211 · 2024: $2,843 · 2025: $2,314.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,356 · Education: $12.01.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,356.14 |
| Education | $12.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,130.34 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Novo Nordisk INC | $1,124.34 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,124.29 | 2019-2025 | Jardiance, Synjardy, Tradjenta |
| Astrazeneca Pharmaceuticals LP | $1,071.95 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Lilly USA, LLC | $1,053.22 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Amgen INC. | $1,002.69 | 2019-2025 | Evenity, Repatha, Otezla |
| Astellas Pharma US INC | $954.23 | 2019-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $777.88 | 2021-2025 | |
| Pfizer INC. | $740.21 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $597.53 | 2020-2025 | Trintellix |
| Supernus Pharmaceuticals, INC. | $563.73 | 2019-2024 | Qelbree |
| Axsome Therapeutics, INC. | $399.49 | 2022-2025 | Sunosi, Auvelity |
| Janssen Pharmaceuticals, INC | $390.27 | 2019-2024 | Spravato, Xarelto |
| Novartis Pharmaceuticals Corporation | $346.88 | 2019-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $336.24 | 2019-2025 | Xifaxan, Relistor, Trulance |
Show all 62 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $304.82 | 2019-2025 | |
| Amarin Pharma, INC. | $286.54 | 2020-2022 | |
| Dexcom, INC. | $188.00 | 2020-2025 | Dexcom G6 Transmitter |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $185.96 | 2022-2025 | Caplyta |
| E.R. Squibb & Sons, L.L.C. | $181.98 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $146.27 | 2023-2024 | Gemtesa |
| Mylan Specialty L.P. | $142.10 | 2021-2024 | Yupelri |
| Eisai INC. | $120.22 | 2020-2022 | |
| Idorsia Pharmaceuticals US INC | $104.74 | 2022-2024 | Quviviq |
| Exact Sciences Corporation | $104.37 | 2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Biohaven Pharmaceutical Holding Company LTD. | $101.68 | 2022 | |
| Lundbeck LLC | $98.59 | 2023-2025 | Rexulti, Vyepti |
| Genentech USA, INC. | $90.60 | 2019-2021 | |
| Daiichi Sankyo INC. | $84.64 | 2020-2021 | |
| Abbott Laboratories | $77.23 | 2020-2024 | Freestyle Libre 3 |
| Mannkind Corporation | $68.84 | 2021 | |
| Strongbridge US INC. | $66.72 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $66.34 | 2021-2022 | |
| Dynavax Technologies Corporation | $63.88 | 2019-2025 | Heplisav-B |
| Actelion Pharmaceuticals US, INC. | $57.32 | 2021 | |
| Biogen, INC. | $54.32 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $52.46 | 2025 | Rexulti |
| Merck Sharp & Dohme LLC | $51.63 | 2019-2022 | |
| Xeris Pharmaceuticals, INC. | $50.50 | 2021-2022 | |
| Tandem Diabetes Care, INC. | $49.08 | 2021-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Phathom Pharmaceuticals, INC. | $47.56 | 2024-2025 | Voquezna |
| Medtronic, INC. | $47.15 | 2021-2025 | Minimed 780g |
| Lucid Diagnostics INC. | $44.34 | 2022-2023 | |
| Biohaven Pharmaceuticals, INC. | $34.45 | 2021 | |
| Shield Therapeutics INC | $32.79 | 2023 | Accrufer |
| Shire North American Group INC | $31.48 | 2019 | |
| Inspire Medical Systems, INC. | $28.66 | 2024-2025 | Inspire |
| Edwards Lifesciences Corporation | $26.60 | 2025 | Sapien 3 Ultra Resilia |
| Medtronic Minimed, INC. | $26.38 | 2020 | |
| Viatris Specialty LLC | $25.02 | 2025 | Yupelri |
| Corcept Therapeutics | $24.16 | 2021 | |
| Seqirus USA INC | $21.28 | 2025 | Fluad, Flucelvax |
| Allergan, INC. | $20.57 | 2020 | |
| Nestle Healthcare Nutrition INC. | $19.98 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $19.13 | 2020 | |
| Insulet Corporation | $18.61 | 2019 | |
| Sanofi Pasteur INC. | $18.34 | 2019 | |
| Redhill Biopharma INC. | $16.26 | 2020 | |
| Beta Bionics, INC. | $14.46 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Jazz Pharmaceuticals INC. | $13.79 | 2022 | |
| Lifescan, INC. | $13.33 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $12.43 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Curtis Healey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.